Board of Directors

Dr. h. c. Willy Michel - Chairman
Dr. h. c. Willy Michel - Chairman of the Board
Dr. h. c. Willy Michel - Chairman of the Board

Nationality: Switzerland
Year of birth: 1947
Position: Chairman of the Board of Directors
Member1 since: 1984

Dr. h.c. Willy Michel, Chairman of the Board of Directors of Ypsomed Group.

Until April 2003, Willy Michel was the Chairman of the Board of Directors and CEO of Disetronic Holding AG and since 2003 he has been Chairman of the Board of Directors of Ypsomed Holding AG. From August 2011 to June 2014, Willy Michel was Delegate of the Board of Directors and CEO of Ypsomed Holding AG and the Ypsomed Group.

He founded Disetronic together with his brother in 1984 and they were together until his brother’s departure from the business in 1995, whereupon Willy Michel became solely responsible for the development, production, distribution and sale of Disetronic products (until 1999). Within the scope of the sale of Disetronic to Roche Holding AG in 2003, Willy Michel bought back Disetronic’s injection business, which has subsequently traded under the name Ypsomed. Prior to the founding of Disetronic, Willy Michel, who holds a professional qualification as a pharmaceutical consultant with a federal diploma, obtained a broad range of experience with several industrial and pharmaceutical companies in the fields of development, sales and marketing and he was the head of Novo Nordisk Switzerland for six years (from 1978 until 1984).

Willy Michel was the founder, majority shareholder and Chairman of the Board of Directors of the non-listed company Finox AG, with the purpose of development, manufacturing and sale of pharmaceuticals and was sold to Gedeon Richter in 2016. Willy Michel is the Vice Chairman of the Board of Directors of BV Holding AG (Chairman from 2001 until March 2008), an equity investment company which is listed on the BX Swiss AG, and Chairman (since 2012 until the Annual General Meeting 2020, a member since 2007) of the Board of Directors of Adval Tech Holding AG, which is listed on the SIX Swiss Exchange. He is also Chairman of the Board of Directors of Solarstadt Burgdorf AG. Since 2016 he has been an honorary member in the Association of the Institute for Organisation and Personnel of the University of Berne.

In June 2017, Willy Michel founded the Diabetes Center Berne Foundation (DCB), which works closely with the University Hospital of the Insel Group. Willy Michel is Chairman of the Board of Trustees of DCB. In addition, he is the owner of a number of companies, including well-known firms involved in the fields of art, watch-making and catering, and is a member of the Boards of Directors of various non-listed companies operating in different sectors from the Ypsomed Group and of no significance to its business activities.

Willy Michel was declared the “Master Entrepreneur of the Year” for his overall business performance by Ernst & Young AG in 2005 and in 2006 he was awarded an honorary doctorate (Dr. h. c.) by the Economic and Social Science Faculty of the University of Bern. In 2014, the Swiss Association for Internal and Integrated Communication (SVIK) awarded Willy Michel as “Communicator of the Year” (COTY).

Gilbert Achermann - Member
Gilbert Achermann, member of the Board of Directors of Ypsomed Group.
Gilbert Achermann, member of the Board of Directors of Ypsomed Group

Nationality: Switzerland
Year of birth: 1964
Position: Member of the Board of Directors
Member2 since: 2020

Gilbert Achermann, member of the Board of Directors of Ypsomed Group.

Gilbert Achermann is Chairman of the Board of the Straumann Group, the global market leader in implant dentistry and member of the Board of Directors of Vifor Pharma AG and the Julius Baer Group AG. At the IMD Lausanne he is a member of the supervisory board and a committee member of the Chamber of Commerce of both Basle cantons. He is also involved as an investor & business angel for start-ups. Previously he held mandates as Chairman & Co-CEO of Vitra Holding AG and Chairman of Siegfried Holding AG. He started his career at UBS in the investment banking division. He has a Bachelor degree from the University of Applied Sciences St. Gallen and an Executive MBA from IMD.

 

Paul Fonteyne - Member
Paul Fonteyne, member of the Board of Directors
Paul Fonteyne, member of the Board of Directors

Nationality: US and Belgium
Year of birth: 1961
Position: Member of the Board of Directors
Member2 since: 2018

Paul Fonteyne, member of the Board of Directors of Ypsomed Group.

After graduating from Brussels University with a degree in chemical engineering and an MBA from Carnegie Mellon University in Pittsburgh, he held various positions at Abbott Laboratories Inc. and Merck and Co. Inc. He joined the Boehringer Ingelheim Group in 2003. For the first five years, he headed the Human Pharmaceuticals Division in the USA. From 2008 to 2011, he lived in Germany to lead the worldwide marketing team for human pharmaceuticals. During his tenure at Boehringer Ingelheim, the company experienced strong sales, profit and profitability growth in the USA.

From 2012 to 2018, he was Chairman of the Board of Directors and CEO of Boehringer Ingelheim USA as well as Country Managing Director for the United States. Paul Fonteyne previously served as Chairman of the National Pharmaceutical Council (NPC), and was a member of the board of Pharmaceutical Research and Manufacturers of America (PhRMA). He is currently a member of the Board of Directors of the four clinical phase biotechnology companies ResTORbio Inc, Gelesis Inc and Apellis Pharmaceuticals Inc, all based in Boston, and DalCor Inc, based in London. He also serves on the Board of Directors of AMAG Pharmaceuticals Inc. in the Boston area. He is associated as Executive in Residence with Canaan Partners (Venture Capital).

Dr. Martin Münchbach - Member
Dr. Martin Münchbach, member of the Board of Directors  and Compensation Committee
Dr. Martin Münchbach, member of the Board of Directors and Compensation Committee

Nationality: Germany and Switzerland
Year of birth: 1970
Position: Member of the Board of Directors
Member2 since: 2019

Dr. Martin Münchbach, member of the Board of Directors of Ypsomed Group.

After graduating from the ETH Zurich in natural sciences with a doctorate in protein chemistry and a post-graduate degree in economics, business and management sciences from the ETH Zurich, he worked in various positions for venture capital companies in Switzerland.

Since 2004, he has been Senior Investment Advisor Private Equity at Bellevue Asset Management AG in Küsnacht, ZH and is currently Managing Partner of BB Pureos Bioventures, a venture capital company specializing in early-stage financing for the promotion of innovative young drug development companies with a focus on Switzerland and Europe. Through his work as a venture capitalist, he has built up numerous medical technology and biotechnology companies that have brought innovative drugs and diagnostics to market. Martin Münchbach has served on the

Board of Directors of 4-Antibody AG in Basel, Optimer Pharmaceuticals Inc. in San Diego, USA and Radius Health Inc. in Waltham, USA, among others. He is currently a Director of Alentis Therapeutics AG in Basel and Binx Health Ltd. in Trowbridge, UK.

 

1 Until April 2003, Willy Michel was a member of the Executive Management of Disetronic Holding AG and from 2003 to August 2011 he was the non-executive Chairman of the Board of Directors of Ypsomed Holding AG. From August 2011 to June 2014, Willy Michel was Delegate of the Board of Directors and CEO of Ypsomed Holding AG and the Ypsomed Group. Since July 2014, he has been the non-executive Chairman of the Board of Directors of Ypsomed Holding AG.

2 Non-executive member of the Board of Directors, member of the Compensation Committee: no operational activity for
Ypsomed Holding AG and its subsidiaries in the current year and the three preceding financial years.

Executive Management

Simon Michel - CEO of the Ypsomed Holding AG and the Ypsomed Group
Simon Michel - CEO of Ypsomed Holding AG and the Ypsomed Group
Simon Michel - CEO of Ypsomed Holding AG and the Ypsomed Group

Nationality: Switzeland
Year of birth: 1977
Position: CEO of the Ypsomed Holding AG and the Ypsomed Group
At Ypsomed since: 2006

CEO of the Ypsomed Holding AG and the Ypsomed Group

  • With Ypsomed since October 2006
  • Member of Executive Management since 2008 and responsible for Marketing & Sales
  • CEO since July 2014.

From 2003 until 2006, Simon Michel worked for Orange Communications AG, where he was responsible for, among other things, the introduction and marketing of UMTS.

Simon Michel studied economics at the University of St. Gallen and completed a Masters with a focus on media and communications management.

He is a Member of the Board of Directors of Unitectra AG, sitem-insel AG and Forster Rohner AG. Simon Michel has been a member of the board of the Chamber of Commerce in the Cantons of Berne and Solothurn and since 2015 a member of the board of Swiss Medtech, the umbrella association of Swiss medtech, and other boards of trustees and advisory boards since 2015.

In June 2017, Simon Michel’s father, Willy Michel, founded the Diabetes Center Berne Foundation (DCB), which works closely with the University Hospital of the Insel Group and is researching new therapeutic approaches to improve the quality of life of people with diabetes. Simon Michel is Chairman of the Board of Directors of DCB Research AG, a 100 % subsidiary of the foundation.

Simon Michel was elected to the Cantonal Council of the Canton of Solothurn in March 2017.

 

Frank Mengis - Chief Operating Officer (COO)
Frank Mengis - Chief Operating Officer (COO)
Frank Mengis - Chief Operating Officer (COO)

Nationality: Germany and Switzerland
Year of birth: 1964
Position: Chief Operating Officer (COO)
At Ypsomed since: 2015

Chief Operating Officer (COO)

With Ypsomed since 2015 as a Member of Executive Management and responsible for Production, Supply Chain and QM&RA.

He has many years of experience in the development and manufacturing of medical devices: former COO and member of management at Nobel Biocare AG, responsible for the global production sites and global supply chain. In the years 2001 to 2012 he held various management functions in the Straumann Group in Switzerland and the USA in the areas of quality management, production and development.

After graduating, he started his career at Hoffmann La Roche AG in Basle in the Engineering Department (1990 – 1999). Of German-Swiss dual nationality, he graduated as Dipl. Ing. Mechanical Engineering from the Technical University Karlsruhe followed by further training at the IMD Lausanne and the Harvard Business School (AMP Programme).

He has been a member of the Board of Qualitech AG since 2017.

Hans Ulrich Lehmann - Senior Vice President Technology
Hans Ulrich Lehmann - Senior Vice President Technology
Hans Ulrich Lehmann - Senior Vice President Technology

Nationality: Switzerland
Year of birth: 1966
Position: SVP Technology
At Ypsomed since: 2000

Senior Vice President Technology

From April to September 2015, Hans Ulrich Lehmann managed Operations on an interim basis. He has been a member of Executive Management since 2011 and is responsible for Technology.

He has been with Ypsomed since 2000 (pre-2003 at Disetronic) in different positions, initially as Senior Project Manager for R & D projects, before spending several years as Vice President Manufacturing and Vice President Technology. Previously, he worked at various medical device manufacturing and injection moulding companies in Switzerland and the USA.

He graduated as a mechanical engineer and completed the postgraduate programme in business administration at the University of Applied Sciences in Bern and also completed the Programme for Leadership Development PLD at Harvard Business School in Boston, USA.

Dr. Eberhard Bauer - Senior Vice President Diabetes Care
Dr. Eberhard Bauer - Senior Vice President Marketing & Sales Diabetes Care
Dr. Eberhard Bauer - Senior Vice President Marketing & Sales Diabetes Care

Nationality: Germany
Year of birth: 1960
Position: SVP Marketing & Sales Diabetes Care
At Ypsomed since: 2012

Senior Vice President Diabetes Care

Since July 2014, member of Executive Management and responsible for the Diabetes Care business area.

Eberhard Bauer was responsible for the global distribution and the distribution companies of Diabetes Care from July 2012 until July 2014. Prior to this, he held various functions with Boehringer Mannheim and Roche Diagnostics over more than 20 years, including Division Head Iberia, Global Head of Marketing and Product Development for Roche Diabetes Care and most recently, Head Latin America.

He graduated as Dr. med. vet. from the Ludwig-Maximilian-University Munich and carried out postgraduate studies at IMD Lausanne and the London Business School.

Ulrike Bauer and Eberhard Bauer are not related in any way.

Ulrike Bauer - Senior Vice President Delivery Systems
Ulrike Bauer - Senior Vice President Marketing & Sales Delivery Systems
Ulrike Bauer - Senior Vice President Marketing & Sales Delivery Systems

Nationality: Germany and Switzerland
Year of birth: 1969
Position: SVP Marketing & Sales Delivery Systems
At Ypsomed since: 2001

Senior Vice President Delivery Systems

 

With Ypsomed (pre-2003 with Disetronic) since 2001 in different functions and since 2014 a member of Executive Management and responsible for the Delivery Systems business area. Previously Product Manager with Mettler Toledo (1996 – 2001).

She has a degree in chemical engineering and biotechnology at the University of Applied Sciences Aachen and completed a postgraduate diploma in International Management at the Kalaidos University of Applied Sciences in Zurich.

Ulrike Bauer and Eberhard Bauer are not related in any way.  

Niklaus Ramseier - Chief Financial Officer (CFO)
Niklaus Ramseier - CFO
Niklaus Ramseier - CFO

Nationality: Switzerland
Year of birth: 1963
Position: Chief Financial Officer (CFO)
At Ypsomed since: 2002

Chief Financial Officer (CFO)

With Ypsomed (pre-2003 with Disetronic) since 2002, prior to that Head of Finance and Controlling for the industrial services product line of the Von Roll Group (from 1995 until 2002) and various advisory and accounting functions within a trust and auditing company. Education: Swiss certified expert in accounting and controlling.

Michael Zaugg - Senior Vice President Human Resources
Michael Zaugg - Senior Vice President Human Resources
Michael Zaugg - Senior Vice President Human Resources

Nationality: Switzerland
Year of birth: 1972
Position: SVP Human Resources
At Ypsomed since: 2017

Senior Vice President Human Resources

With Ypsomed since 2017. From 2011 to 2017 he was employed as Head of Talent Europe at ABB. Previous positions included HR at Credit Suisse: Division HR Manager, Head of Graduate Recruiting & Development and University Marketing (1997 to 2004), Consultant and Management Member at schärpartners ag (2004 to 2007), Head of HR Services at Valiant Holding (2007 to 2008), Head of HR Recruiting at BKW FMB AG (2008 to 2011).

Michael Zaugg held several part-time mandates: Member of the Board of Directors at Poolside AG in Zurich, Member of the Board at IngCH, lecturer at the ZfU and the University of St. Gallen Further Education Centre in the field of Talent Management, as well as the University of Bern on the topic of “Leadership in an innovative environment”, and President of the ABB Childcare Centres.

Education: studied Economics at the University of Basel (degree: lic.rer.pol) with business focus on personnel management and marketing. Executive Master of Human Resources Management at the Institute for Applied Psychology in Zurich.

Dr. Beat Maurer - Senior Vice President Legal and Intellectual Property, Secretary to the Board
Dr. Beat Maurer - Senior Vice President Legal and Intellectual Property
Dr. Beat Maurer - Senior Vice President Legal and Intellectual Property

Nationality: Switzerland
Year of birth: 1958
Position: SVP Legal & Intellectual Property, Secretary of the Board
At Ypsomed since: 1992

Attorney-at-law, Senior Vice President Legal and Intellectual Property, Secretary to the Board of Directors of Ypsomed Holding AG

With Ypsomed (pre-2003 with Disetronic) since 1992, prior to that tax and legal consultant with a trust and auditing company.

Education: degree in Law from the University of Fribourg, studied at the Free University of Berlin, took a doctorate in law at the University of Bern and was admitted to the bar in the Canton of Bern.

Beat Maurer has been a judge specialising in issues relating to business law and intellectual property law at the commercial court of the Canton of Bern since 2002. He is also President of Swiss Medtech’s “Legal & Compliance” Group, the umbrella organisation for Swiss medical technology Swiss Medtech.